US2012156274A1PendingUtilityA1
Infection-resistant polyurethane foams, method for producing the same and use thereof in antiseptic wound dressing
Est. expiryDec 21, 2024(expired)· nominal 20-yr term from priority
A61L 15/44A61L 2300/45A61L 2300/412A61L 2300/404C08L 75/08C08G 2101/00A61L 15/26C08G 18/4841A61L 2300/408A01N 25/34A61L 2300/402A01N 25/10A61L 15/60A01N 47/44A61L 15/425A61L 2300/406C08G 18/73C08L 75/04C08G 18/4825A61L 2300/206
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention describes microbicidal hydrophilic polyurethane foams endowed with polyhexamethylenebiguanide (PHMB) and/or its hydrochloride and also a superabsorbent, wound contact materials obtainable therefrom and processes for producing the therapeutically endowed polyurethane foams and the wound contact materials obtainable therefrom.
Claims
exact text as granted — not AI-modified1 . A cellular hydrophilic polyurethane gel containing an antiseptic agent polyhexamethylenebiguanide and/or a hydrochloride thereof and a superabsorbent, wherein the antiseptic agent is present in the polyurethane gel as a microparticulate dispersion and/or homogenous solution.
2 . A process for producing the cellular hydrophilic polyurethane gel according to claim 1 by reaction of monomers and a foaming agent in the presence of any desired active, wherein at least one active is mixed into a mixture of the monomers before polymerization.
3 . A method for producing medical equipment comprising:
obtaining cellular hydrophilic polyurethane gel according to claim 1 ; and using said polyurethane gel to produce said equipment.
4 . A method for producing an at least one-ply wound contact material comprising:
obtaining the polyurethane gel according to claim 1 ; and using said polyurethane gel to produce said contact material.
5 . A method for producing a wound contact material for large or chronic wounds comprising:
obtaining the polyurethane gel according to claim 1 ; and using said polyurethane gel to produce said contact material.
6 . A wound contact material comprising at least one cellular hydrophilic polyurethane gel according to claim 1 .
7 . The cellular hydrophilic polyurethane gel according to claim 1 , wherein the antiseptic agent is present as a microparticular dispersion comprising a substantially uniform dispersion of antiseptic agent, dispersed in the polyurethane gel in finely grounded or micronized form.
8 . The cellular hydrophilic polyurethane gel according to claim 7 , wherein the antiseptic agent is of particle size 0.5 to 50 μm.
9 . The cellular hydrophilic polyurethane gel according to claim 8 , wherein the antiseptic agent is of particle size 1 to 5 μm.
10 . The cellular hydrophilic polyurethane gel according to claim 1 , wherein the antiseptic agent is of particle size 0.5 to 50 μm.
11 . The cellular hydrophilic polyurethane gel according to claim 1 , wherein the antiseptic agent is of particle size 1 to 5 μm.
12 . The cellular hydrophilic polyurethane gel according to claim 1 , wherein the antiseptic agent is present as a particulate dispersion.
13 . The cellular hydrophilic polyurethane gel according to claim 1 , wherein the antiseptic agent is present as a homogeneous solution.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.